Journal article
Barrett's esophagus: progression to adenocarcinoma and markers
Annals of the New York Academy of Sciences, Vol.1232(1), pp.210-229
09/2011
DOI: 10.1111/j.1749-6632.2011.06053.x
PMID: 21950815
Abstract
The following on progression to adenocarcinoma and markers of Barrett's esophagus includes commentariess on the expression of claudin 4 in Barrett's adenocarcinoma; the role of acid and bile salts; the role of insulin-like growth factor; the value of reactive oxygen species; the importance of abnormal methylation; genetic alterations in stromal cells and genomic changes in the epithelial cells; the value of confocal laser endomicroscopy for the subsurface analysis of the mucosa; indications for statins as adjuvant chemotherapeutic agent; the sequence of molecular events in malignant progression in Barrett's mucosa; and the value of the macroscopic markers and of p53 mutations.
Details
- Title: Subtitle
- Barrett's esophagus: progression to adenocarcinoma and markers
- Creators
- Dianchun Fang - South West Hospital, Third Military Medical University, Chongqing, ChinaKiron M DasWeibiao CaoUsha MalhotraGeorge TriadafilopoulosRobert M NajarianLaura J HardieCharles J LightdaleIan L P BealesValter Nilton FelixPaul M SchneiderAndrew M Bellizzi
- Resource Type
- Journal article
- Publication Details
- Annals of the New York Academy of Sciences, Vol.1232(1), pp.210-229
- DOI
- 10.1111/j.1749-6632.2011.06053.x
- PMID
- 21950815
- NLM abbreviation
- Ann N Y Acad Sci
- ISSN
- 0077-8923
- eISSN
- 1749-6632
- Publisher
- Blackwell Publishing Ltd; United States
- Grant note
- R01 DK080703 / NIDDK NIH HHS
- Language
- English
- Date published
- 09/2011
- Academic Unit
- Pathology
- Record Identifier
- 9984047702102771
Metrics
29 Record Views